Dr. Marasco is an associate professor in the Department of Cancer Immunology and AIDS at the Dana-Farber Cancer Institute and associate professor of Medicine at Harvard Medical School. Dr. Marasco is a licensed physician-scientist with training in internal medicine and specialty training in infectious diseases. His clinical practice sub-specialty is in the treatment of immunocompromised (cancer, bone marrow, and solid organ transplant) patients. Dr. Marasco’s research laboratory is primarily focused on the areas of therapeutic human monoclonal antibody and adult stem cell (ASC) development. In the former, studies include developing passive immunotherapy to prevent and treat global and emerging infectious diseases. Their most recent and highly touted discovery was in the development of the “universal” influenza human antibody passive vaccines that are active against seasonal influenza, avian “bird” flu, and the 2009 pandemic H1N1 influenza strains. They are also developing antibody and cellular therapies for cancer. In the area of adult stem cells, Dr. Marasco heads an HMS team that is investigating the pluripotent potential of ASCs using “humanized mice” as models for host immunity, vaccine development, and regenerative medicine.